查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1678457

美國乾眼症治療市場：市場規模、佔有率、趨勢分析（按類型、藥物、劑型、銷售管道、分銷管道）、細分市場預測（2025-2030 年）

U.S. Dry Eye Syndrome Treatment Market Size, Share & Trends Analysis Report By Type, By Drugs, By Product, By Dosage Form, By Sales Channel, By Distribution Channel, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

美國乾眼症治療市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，美國乾眼症治療市場規模預計到2030年將達到34.7億美元，預測期內的複合年成長率為6.0%。

美國乾眼症（DED）市場的成長很大程度上是由其高盛行率所推動的。到 2024 年，大約 6.8% 的成年人口將被診斷出患有這種疾病，隨著老齡化的成長，患病率會顯著增加，尤其是在女性中。

龐大的患者群體凸顯了對有效治療方案的迫切需求，這為滿足該群體需求的主要企業創造了一個蓬勃發展的市場。人口老化，特別是65歲以上的人口老化是導致DED發病率上升的主要原因。這種人口結構的變化導致治療需求增加，製藥公司和醫療保健提供者也調整了其策略。

2023 年和 2024 年，隨著人們對使用數位設備時間增加導致的 DED 認知的不斷提高，需求將進一步激增。治療方案的創新，包括處方藥和非處方藥（OTC），正在提高診斷率。到 2025 年，Reproxalap、IC 265 和 Acoltremon 等較新的治療藥物有望增強緩解效果並推動未來的市場擴張。

美國乾眼症治療市場：概述

  • 大約2000萬美國中DED的發生率不斷上升，凸顯了迫切的治療需求和公司的市場機會。
  • 從類型來看，蒸發過強型乾眼症將佔據主導地位，佔2024年總銷售額的82.5%。
  • 按藥物分類，Cequa 預計在預測期內以最快的複合年成長率成長 27.0%。
  • 從產品角度來看，Cyclosporine在 2024 年憑藉其在治療乾眼症、顯著增加淚液分泌和抑制發炎方面所展現的臨床療效引領市場。
  • 眼藥水，尤其是人工淚液，可以滋潤眼睛並模仿自然淚液，從而快速緩解乾眼症狀。
  • 根據處方箋，預計成藥在預測期內的複合年成長率最快，為 6.5%。
  • 零售藥局將主導市場，其中線上藥局在預測期內的複合年成長率最快，為 6.6%。
  • 2024 年 8 月，OCuSOFT 在美國推出了處方箋強度抗組織胺 Retaine Allergy，加強了其專注於乾眼症治​​療和緩解過敏的產品線。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

第 3 章美國乾眼症治療市場：促進因素、趨勢與範圍

  • 市場聯動展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 商業環境分析
    • 產業分析：波特五力分析
    • PESTEL 分析

第 4 章美國乾眼症治療市場：按類型分類的業務分析

  • 按類型分類的市場佔有率（2024 年和 2030 年）
  • 按類型分類的儀表板
  • 按類型分類的市場規模預測及趨勢分析（2018-2030）
  • 蒸發
  • 水樣淚液缺乏型

第 5 章美國乾眼症治療市場：藥物業務分析

  • 按藥物類型分類的市場佔有率（2024 年和 2030 年）
  • 藥物儀錶板
  • 依藥物類型分類的市場規模預測及趨勢分析（2018-2030年）
  • 汐多拉
  • 雷斯塔西斯
  • 塞誇
  • 蒂亞
  • 阿塞維斯
  • 其他

第6章美國乾眼症治療市場：按產品分類的業務分析

  • 按產品市場佔有率（2024 年和 2030 年）
  • 產品儀表板
  • 依產品分類的市場規模預測及趨勢分析（2018-2030）
  • 人工淚液
  • Cyclosporine
  • 局部固醇
  • 淚點塞
  • 口服歐米茄補充劑
  • 其他

第 7 章美國乾眼症治療市場：按劑型分類的業務分析

  • 按劑型分類的市場佔有率（2024 年及 2030 年）
  • 配方儀表板
  • 按劑型分類的市場規模預測及趨勢分析（2018-2030年）
  • 眼藥水/溶液
  • 軟膏和凝膠
  • 膠囊和錠劑
  • 其他

第 8 章美國乾眼症治療市場：按銷售管道的業務分析

  • 按銷售管道分類的市場佔有率（2024 年和 2030 年）
  • 銷售管道儀表板
  • 依銷售管道分類的市場規模預測及趨勢分析（2018-2030 年）
  • 處方藥
  • 場外交易（OTC）

第 9 章美國乾眼症治療市場：按分銷管道分類的業務分析

  • 按分銷管道分類的市場佔有率（2024 年和 2030 年）
  • 分銷通路儀表板
  • 按分銷管道分類的市場規模預測及趨勢分析（2018-2030 年）
  • 分銷通路市場佔有率，2024 年和 2030 年
  • 分銷通路細分儀表板
  • 2018 年至 2030 年按分銷管道分類的市場規模、預測和趨勢分析
  • 零售藥局
  • 醫院藥房
  • 網路藥局

第10章 競爭格局

  • 參與者概述
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • Novartis AG
    • AbbVie Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Janssen Pharmaceutica（Pty.）Ltd.
    • OASIS Medical, Inc.
    • Viatris Inc.
    • Bausch Health Companies Inc.
    • Santen Pharmaceutical Co., Ltd.
Product Code: GVR-4-68040-514-4

U.S. Dry Eye Syndrome Treatment Market Growth & Trends:

The U.S. dry eye syndrome treatment market size is anticipated to reach USD 3.47 billion by 2030 and is anticipated to expand at a CAGR of 6.0% during the forecast period, according to a new report by Grand View Research, Inc. Market growth in the U.S. for dry eye disease (DED) has been significantly influenced by its high prevalence. By 2024, this condition has shown notable age-related increases, particularly among women, with around 6.8% of the adult population diagnosed.

The substantial patient base has highlighted the urgent need for effective treatment options, leading to a burgeoning market for companies catering to this demographic's needs. The aging population, particularly those aged 65 and older, has significantly contributed to the rising incidence of DED. This demographic shift has created increased demand for treatment as pharmaceutical companies and healthcare providers have adapted their strategies.

In 2023 and 2024, heightened awareness of DED, linked to increased screen time from digital devices, has further surged demand. Innovations in treatment options, including prescription medications and over-the-counter (OTC) products, have improved diagnosis rates. By 2025, new therapies such as Reproxalap, IC 265, and Acoltremon are anticipated to enhance relief and drive future market expansion.

U.S. Dry Eye Syndrome Treatment Market Report Highlights:

  • The growing prevalence of DED in approximately 20 million Americans highlights urgent treatment needs and market opportunities for companies.
  • Based on type, evaporative dry eye syndrome dominated the type segment, accounting for 82.5% of the total revenue share in 2024.
  • Based on drugs, Cequa is projected to grow at the fastest CAGR of 27.0% over the forecast period.
  • Based on product, cyclosporine led the market in 2024, demonstrating clinical efficacy in treating dry eye syndrome, significantly increasing tear production and reducing inflammation.
  • Eye drops, especially artificial tears, offer rapid relief from dry eye symptoms by lubricating the eyes and mimicking natural tears, thus dominating the dosage form segment in 2024.
  • Based on prescription, OTC drugs are expected to register the fastest CAGR of 6.5% over the forecast period.
  • Retail pharmacies dominated the market, with online pharmacies exhibiting the fastest CAGR of 6.6% over the forecast period.
  • In August 2024, OCuSOFT launched Retaine Allergy prescription-strength antihistamine drops in the U.S., enhancing its product line focused on dry eye solutions and allergy relief.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Drugs
    • 1.2.3. Product
    • 1.2.4. Dosage Form
    • 1.2.5. Sales Channel
    • 1.2.6. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Dry Eye Syndrome Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. U.S. Dry Eye Syndrome Treatment Market: Type Business Analysis

  • 4.1. Type Market Share, 2024 & 2030
  • 4.2. Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Evaporative
    • 4.4.1. Evaporative Market, 2018 - 2030 (USD Million)
  • 4.5. Aqueous Deficient
    • 4.5.1. Aqueous Deficient Market, 2018 - 2030 (USD Million)

Chapter 5. U.S. Dry Eye Syndrome Treatment Market: Drugs Business Analysis

  • 5.1. Drugs Market Share, 2024 & 2030
  • 5.2. Drugs Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Drugs, 2018 to 2030 (USD Million)
  • 5.4. Xiidra
    • 5.4.1. Xiidra Market, 2018 - 2030 (USD Million)
  • 5.5. Restasis
    • 5.5.1. Restasis Market, 2018 - 2030 (USD Million)
  • 5.6. Cequa
    • 5.6.1. Cequa Market, 2018 - 2030 (USD Million)
  • 5.7. Tyrvaya
    • 5.7.1. Tyrvaya Market, 2018 - 2030 (USD Million)
  • 5.8. Eysuvis
    • 5.8.1. Eysuvis Market, 2018 - 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. U.S. Dry Eye Syndrome Treatment Market: Product Business Analysis

  • 6.1. Product Market Share, 2024 & 2030
  • 6.2. Product Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 6.4. Artificial Tears
    • 6.4.1. Artificial Tears Market, 2018 - 2030 (USD Million)
  • 6.5. Cyclosporine
    • 6.5.1. Cyclosporine Market, 2018 - 2030 (USD Million)
  • 6.6. Topical Corticosteroids
    • 6.6.1. Topical Corticosteroids Market, 2018 - 2030 (USD Million)
  • 6.7. Punctal Plugs
    • 6.7.1. Punctal Plugs Market, 2018 - 2030 (USD Million)
    • 6.7.2. Removable
      • 6.7.2.1. Removable Market, 2018 - 2030 (USD Million)
    • 6.7.3. Dissolvable
      • 6.7.3.1. Dissolvable Market, 2018 - 2030 (USD Million)
  • 6.8. Oral Omega Supplements
    • 6.8.1. Oral Omega Supplements Market, 2018 - 2030 (USD Million)
  • 6.9. Others
    • 6.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. U.S. Dry Eye Syndrome Treatment Market: Dosage Form Business Analysis

  • 7.1. Dosage Form Market Share, 2024 & 2030
  • 7.2. Dosage Form Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Dosage Form, 2018 to 2030 (USD Million)
  • 7.4. Eye Drops / Solutions
    • 7.4.1. Eye Drops / Solutions Market, 2018 - 2030 (USD Million)
  • 7.5. Ointments and Gels
    • 7.5.1. Ointments and Gels Market, 2018 - 2030 (USD Million)
  • 7.6. Capsules & Tablets
    • 7.6.1. Capsules & Tablets Market, 2018 - 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others Market, 2018 - 2030 (USD Million) Market, 2018 - 2030 (USD Million)

Chapter 8. U.S. Dry Eye Syndrome Treatment Market: Sales Channel Business Analysis

  • 8.1. Sales Channel Market Share, 2024 & 2030
  • 8.2. Sales Channel Segment Dashboard
  • 8.3. Market Size & Forecasts and Trend Analysis, by Sales Channel, 2018 to 2030 (USD Million)
  • 8.4. Prescription
    • 8.4.1. Prescription Market, 2018 - 2030 (USD Million)
  • 8.5. OTC
    • 8.5.1. OTC Market, 2018 - 2030 (USD Million)

Chapter 9. U.S. Dry Eye Syndrome Treatment Market: Distribution Channel Business Analysis

  • 9.1. Distribution Channel Market Share, 2024 & 2030
  • 9.2. Distribution Channel Segment Dashboard
  • 9.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 9.4. Retail Pharmacies
    • 9.4.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • 9.5. Hospital Pharmacies
    • 9.5.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • 9.6. Online Pharmacies
    • 9.6.1. Online Pharmacies Market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Participant Overview
  • 10.2. Company Market Position Analysis
  • 10.3. Company Categorization
  • 10.4. Strategy Mapping
  • 10.5. Company Profiles/Listing
    • 10.5.1. Novartis AG
      • 10.5.1.1. Overview
      • 10.5.1.2. Financial Performance
      • 10.5.1.3. Product Benchmarking
      • 10.5.1.4. Strategic Initiatives
    • 10.5.2. AbbVie Inc.
      • 10.5.2.1. Overview
      • 10.5.2.2. Financial Performance
      • 10.5.2.3. Product Benchmarking
      • 10.5.2.4. Strategic Initiatives
    • 10.5.3. Sun Pharmaceutical Industries Ltd.
      • 10.5.3.1. Overview
      • 10.5.3.2. Financial Performance
      • 10.5.3.3. Product Benchmarking
      • 10.5.3.4. Strategic Initiatives
    • 10.5.4. Janssen Pharmaceutica (Pty.) Ltd.
      • 10.5.4.1. Overview
      • 10.5.4.2. Financial Performance
      • 10.5.4.3. Product Benchmarking
      • 10.5.4.4. Strategic Initiatives
    • 10.5.5. OASIS Medical, Inc.
      • 10.5.5.1. Overview
      • 10.5.5.2. Financial Performance
      • 10.5.5.3. Product Benchmarking
      • 10.5.5.4. Strategic Initiatives
    • 10.5.6. Viatris Inc.
      • 10.5.6.1. Overview
      • 10.5.6.2. Financial Performance
      • 10.5.6.3. Product Benchmarking
      • 10.5.6.4. Strategic Initiatives
    • 10.5.7. Bausch Health Companies Inc.
      • 10.5.7.1. Overview
      • 10.5.7.2. Financial Performance
      • 10.5.7.3. Product Benchmarking
      • 10.5.7.4. Strategic Initiatives
    • 10.5.8. Santen Pharmaceutical Co., Ltd.
      • 10.5.8.1. Overview
      • 10.5.8.2. Financial Performance
      • 10.5.8.3. Product Benchmarking
      • 10.5.8.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. U.S. dry eye syndrome treatment market, by region, 2018 - 2030 (USD Million)
  • Table 4. U.S. dry eye syndrome treatment market, by type, 2018 - 2030 (USD Million)
  • Table 5. U.S. dry eye syndrome treatment market, by drugs, 2018 - 2030 (USD Million)
  • Table 6. U.S. dry eye syndrome treatment market, by product, 2018 - 2030 (USD Million)
  • Table 7. U.S. dry eye syndrome treatment market, by dosage form, 2018 - 2030 (USD Million)
  • Table 8. U.S. dry eye syndrome treatment market, by sales channel, 2018 - 2030 (USD Million)
  • Table 9. U.S. dry eye syndrome treatment market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 U.S. dry eye syndrome treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Type and drugs outlook (USD Million)
  • Fig. 10 Product and dosage form outlook (USD Million)
  • Fig. 11 Sales channel and distribution channel outlook (USD Million)
  • Fig. 12 Competitive landscape
  • Fig. 13 U.S. dry eye syndrome treatment market dynamics
  • Fig. 14 U.S. dry eye syndrome treatment market: Porter's five forces analysis
  • Fig. 15 U.S. dry eye syndrome treatment market: PESTLE analysis
  • Fig. 16 U.S. dry eye syndrome treatment market: Type segment dashboard
  • Fig. 17 U.S. dry eye syndrome treatment market: Type market share analysis, 2024 & 2030
  • Fig. 18 U.S. dry eye syndrome treatment market: Drugs segment dashboard
  • Fig. 19 U.S. dry eye syndrome treatment market: Drugs market share analysis, 2024 & 2030
  • Fig. 20 U.S. dry eye syndrome treatment market: Product segment dashboard
  • Fig. 21 U.S. dry eye syndrome treatment market: Product market share analysis, 2024 & 2030
  • Fig. 22 U.S. dry eye syndrome treatment market: Dosage form segment dashboard
  • Fig. 23 U.S. dry eye syndrome treatment market: Dosage form market share analysis, 2024 & 2030
  • Fig. 24 U.S. dry eye syndrome treatment market: Sales channel segment dashboard
  • Fig. 25 U.S. dry eye syndrome treatment market: Sales channel market share analysis, 2024 & 2030
  • Fig. 26 U.S. dry eye syndrome treatment market: Distribution channel segment dashboard
  • Fig. 27 U.S. dry eye syndrome treatment market: Distribution channel market share analysis, 2024 & 2030
  • Fig. 28 Company categorization
  • Fig. 29 Company market position analysis
  • Fig. 30 Strategic framework